| Withdrawn | Phase 3 Study to Evaluate the Lot Consistency of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine COVID-19 | Phase 3 | 2021-11-22 |
| Terminated | Safety Immunogenicity Study of MT-2766 in Japanese Adults（COVID-19） SARS-CoV-2 Infection | Phase 1 / Phase 2 | 2021-10-02 |
| Active Not Recruiting | Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults SARS-CoV-2 Infection | Phase 2 / Phase 3 | 2020-11-19 |
| Completed | Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years Influenza | Phase 1 / Phase 2 | 2020-11-02 |
| Completed | Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 SARS-CoV 2 | Phase 1 | 2020-07-10 |
| Completed | Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases | Phase 3 | 2018-09-18 |
| Completed | Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adult Virus Diseases, RNA Virus Infections, Respiratory Tract Infections | Phase 3 | 2017-09-29 |
| Completed | Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vac Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases | Phase 3 | 2017-08-31 |
| Completed | Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adul Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases | Phase 2 | 2016-04-01 |
| Completed | Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases | Phase 2 | 2016-03-02 |
| Completed | Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases | Phase 2 | 2014-07-28 |
| Completed | Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases | Phase 2 | 2014-07-16 |
| Completed | Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adul Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases | Phase 1 | 2013-12-01 |
| Completed | Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases | Phase 1 / Phase 2 | 2013-10-08 |
| Completed | Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine. Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases | Phase 2 | 2013-06-01 |
| Completed | Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults Flu | Phase 1 | 2011-02-01 |
| Completed | Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases | Phase 2 | 2010-11-01 |
| Completed | Safety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy Adults Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases | Phase 1 | 2009-09-01 |